EVERIMMUNE

everimmune-logo

EverImmune focuses on the development of promising projects in the field of microbiome oncology. It is devoted to treating cancer patients. EverImmune provides a series of live biotherapeutic products (LBP), used as oral adjuvants to anticancer immunotherapies. EverImmune plans to test Oncobax® in well-designed clinical trials.

#SimilarOrganizations #People #Website #More

EVERIMMUNE

Social Links:

Industry:
Biotechnology Health Care

Founded:
2016-01-01

Address:
Villejuif, Ile-de-France, France

Country:
France

Website Url:
http://www.everimmune.com

Total Employee:
1+

Status:
Active

Email Addresses:
contact@everimmune.com

Total Funding:
5 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Font Awesome Amazon IPv6 Cloudflare Hosting Amazon S3 Amazon SSL


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

habitual-logo

Habitual

Digital therapeutics & nutritional treatment for type 2 diabetes reversal.

healios-logo

Healios

The UK’s leading digital healthcare company .

inceptor-bio-logo

Inceptor Bio

Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.

likeminded-logo

Likeminded

Likeminded is a operator of a digital mental health platform.

Current Employees Featured

jean-luc-marsat_image

Jean-Luc Marsat
Jean-Luc Marsat Chief Executive Officer @ EverImmune
Chief Executive Officer
2021-10-01

romain-daillère_image

Romain Daillère
Romain Daillère Head of Preclinical Research & Co-founder @ EverImmune
Head of Preclinical Research & Co-founder
2018-05-01

Founder


romain-daillère_image

Romain Daillère

Official Site Inspections

http://www.everimmune.com

  • Host name: 51-159-1-8.rev.poneytelecom.eu
  • IP address: 51.159.1.8
  • Location: Paris France
  • Latitude: 48.8607
  • Longitude: 2.3281
  • Timezone: Europe/Paris
  • Postal: 75001

Loading ...

More informations about "EverImmune"

ABOUT US - VERIMMUNE

VerImmune is biotechnology company developing a novel first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR). This strategy utilizes a proprietary virus-inspired particle …See details»

VerImmune - Crunchbase Company Profile & Funding

Organization. VerImmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... VerImmune may be growing as it has successfully raised $3.1 million for its cancer therapy …See details»

VerImmune Company Profile 2024: Valuation, Funding & Investors …

VerImmune General Information Description. Developer of biotechnology immuno-medicines designed to provide cancer therapy known as anti-tumor immune redirection. The company …See details»

Verimmune Company Profile - Office Locations, Competitors

VerImmune is a biotechnology company specializing in cancer therapy. It develops a new method called Anti-tumor Immune Redirection, a strategy that utilizes a proprietary virus-inspired …See details»

VerImmune - Contacts, Employees, Board Members, Advisors

Organization. VerImmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... and Advisor Profiles 4. Contacts 4. About. VerImmune …See details»

VerImmune - Funding, Financials, Valuation & Investors

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. Search Crunchbase. Start Free Trial . ... How much funding …See details»

EverImmune Company Profile 2024: Valuation, Funding

EverImmune General Information Description. Developer of live biotherapeutic products intended to enhance the efficacy of immunotherapy in cancer patients. The company specializes in …See details»

VerImmune Inc - VentureRadar

VerImmune is pioneering a revolutionary cancer treatment known as Anti-Tumor Immune Redirection (AIR). This innovative therapy leverages pre-existing immune memory from past …See details»

Resident Companies in Action: VerImmune - Children's …

Apr 20, 2023 The VerImmune team. From left to right: Emily De-Bodene, Felagot Abebe, Joshua Wang, Cayce Dorrier and Olivia Pak. This month, the team at Johnson & Johnson Innovation – JLABS @ Washington, DC spoke …See details»

EverImmune - Company Profile - Tracxn

Oct 24, 2024 EverImmune - Developer of biotherapeutics for the treatment of cancer. Raised a total funding of $3.7M over 2 rounds from 2 investors. Founded by Romain Daillere in the year …See details»

Research - Overview, Competitors, and Employees - Apollo.io

EverImmune is a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology. It harnesses the gut microbiota for the …See details»

VerImmune Completes $4.5 Million First Closing of Pre-Series A ...

Sep 23, 2024 VerImmune's primary focus lies in the field of Oncology, wherein the ViP technology enables a pioneering first-in-class cancer immunotherapy approach known as Anti …See details»

VerImmune - Updates, News, Events, Signals & Triggers

Organization. VerImmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . Edit Growth …See details»

Joshua Wang, PHD - BIO Investor Forum | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Prior to VerImmune, Dr Wang …See details»

VerImmune Completes $4.5 Million First Closing of Pre-Series A ...

VerImmune’s primary focus lies in the field of Oncology, wherein the ViP technology enables a pioneering first-in-class cancer immunotherapy approach known as Anti-tumor Immune …See details»

Fosun Pharma and VerImmune enter into an Exclusive License and …

Under the terms of the agreement, VerImmune has granted Fosun Pharma an exclusive license to VerImmune’s lead AIR-ViP product candidate, VERI-101, with an option to license certain …See details»

News - VERIMMUNE

VerImmune Receives SBIR Phase II Award from the National Science Foundation. Read More. joshua wang September 2, 2020. VerImmune Announces New Board, Advisors and Officers . …See details»

How does community immunity work? | Let's Get Real - HHS.gov

2 days ago Germs can travel quickly from person to person. source: 1 And germs that cause infectious diseases can make people very sick. source: 1 Vaccines can help protect people …See details»

VerImmune - BIO Investor Forum | BIO

VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection (AIR). The strategy utilizes a proprietary tumor-specific, tumor …See details»

VerImmune Announces Research Collaboration with Janssen to …

Feb 9, 2022 Baltimore, Maryland., February 8, 2022 – VerImmune Inc. (VerImmune), a biotechnology company developing a new therapeutic modality that redirects the body’s pre …See details»

linkstock.net © 2022. All rights reserved